Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Change in Receivables (2018 - 2025)

Exagen's Change in Receivables history spans 8 years, with the latest figure at -$237000.0 for Q4 2025.

  • For Q4 2025, Change in Receivables rose 84.73% year-over-year to -$237000.0; the TTM value through Dec 2025 reached $3.0 million, up 135.2%, while the annual FY2025 figure was $3.0 million, 135.2% up from the prior year.
  • Change in Receivables reached -$237000.0 in Q4 2025 per XGN's latest filing, up from -$3.6 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $6.9 million in Q2 2023 to a low of -$10.5 million in Q4 2023.
  • Average Change in Receivables over 5 years is $97250.0, with a median of $437000.0 recorded in 2021.
  • Peak YoY movement for Change in Receivables: crashed 1127.48% in 2022, then surged 415.66% in 2023.
  • A 5-year view of Change in Receivables shows it stood at $444000.0 in 2021, then plummeted by 1127.48% to -$4.6 million in 2022, then tumbled by 130.01% to -$10.5 million in 2023, then skyrocketed by 85.21% to -$1.6 million in 2024, then skyrocketed by 84.73% to -$237000.0 in 2025.
  • Per Business Quant, the three most recent readings for XGN's Change in Receivables are -$237000.0 (Q4 2025), -$3.6 million (Q3 2025), and -$1000.0 (Q2 2025).